{"id":482819,"title":"DRAFT Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T19:59:44.659000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/draft-information-submission-requirements-biosimilar-biologic-drugs.html?wbdisable=true","snippet":"DRAFT Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs This guidance is a draft version for consultation purposes only. It is not to be implemented at this time. Please refer to the Consultation on Guidance Document: Information and…","rawSnapshotUrl":"/api/snapshots/raw/482819","browseUrl":"https://replay.healtharchive.ca/job-6/20260106195944/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/draft-information-submission-requirements-biosimilar-biologic-drugs.html?wbdisable=true#ha_snapshot=482819","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}